Public Alert No. 049/2022 – Alert on the UAE health authority warning against consumption of weight loss pills
, The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public that the Department of Health – Abu Dhabi (DOH) has warned against the use of the Weight Rapid Loss Capsule, due to its potential to cause cancer. The product is being -marketed as “the most effective weight loss supplement” […]
Public Alert No. 048/2022 – Warning Against Counterfeit Covid-19 Antigen Rapid Test Kits
, The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying healthcare providers of a safety communication by Health Canada following the discovery of counterfeit BTNX Incorporated COVID-19 rapid antigen test kits in Ontario, Canada. The counterfeit test kits were sold online in 25-pack boxes by a distributor called Healthful Plus without […]
Public Alert No. 047/2022 – Alert On The Distribution And Sale Of Falsified Lantus Solostar Solution For Injection In Prefilled Pens 100 I.U
, The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying Healthcare providers and the public on the distribution and sale of falsified Lantus Solostar Solution for Injection in Prefilled Pens 100 I.U discovered in Lagos Island and reported by Sanofi. The product is referred to as LAN-NI 0011. Laboratory analysis of […]
Public Alert No. 046/2022 – Alert on the Distribution and Sale of Falsified Daonil 5mg Tablets
, The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying Healthcare providers and the public on the distribution and sale of falsified Daonil 5mg tablets discovered in Idumota, Lagos state and reported by Sanofi. The product as reported by Sanofi is referred to as DAO-NI 0016. Laboratory analysis of the product […]
Public Alert No. 045/2022 – Alert on Counterfeit Meronem circulating in Nigeria
, The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying Healthcare providers and the public of the detection of one batch counterfeit Meronem circulating in Nigeria. According to Pfizer, laboratory analysis of the Meronem vial content indicated that there was no meropenem trihydrate detected in the suspect sample but amoxicillin and […]
Public Alert No:044/2022 – Counterfeit Neo Medrol found in Circulation in Nigeria
, The National Agency for Food and Drug Administration and Control (NAFDAC) has been informed by Pfizer Specialties Limited of the circulation of counterfeit Neo -Medrol in Nigeria. Pfizer was informed of a video circulating on the internet advertising Neo Medrol in Nigeria bearing batch CDMPG and expiry date 02/2025. According to Pfizer, the check […]
Public Announcement
, The Management of National Agency for Food and Drug Administration and Control ( NAFDAC) wishes to inform all Stakeholders and the General Public about the expiration of the tenure of office of her Director-General, Prof Moji Christianah Adeyeye. Consequently, the Federal Government has appointed the Agency’s Director of Drug Registration and Regulatory Affairs, Dr […]
Notice To NAFDAC Clients On Implementation Of Tax Identification Number (TIN) Validation Issued By The Federal Inland Revenue Service On The NAFDAC Automated Products Administration And Monitoring System (NAPAMS) For Regulated Products Registration
, Dear Esteemed Client, This is to inform you that NAFDAC has integrated her NAFDAC Automated Products Administration and Monitoring System (NAPAMS) with the Federal Inland Revenue Service (FIRS) Tax Identification Number Database. This is to ensure validation and authentication of Tax Identification Numbers (TIN) submitted by clients on the NAPAMS portal. As a result, […]
ICMRA Communication Campaign: World Antimicrobial Awareness Week 2022
, World Antimicrobial Awareness Week 2022: ICMRA communication campaign Communication toolkit for ICMRA members and partners Background The International Coalition of Medicines Regulatory Authorities (ICMRA) adopted antimicrobial resistance (AMR) as a strategic priority and committed its support for the fight against AMR in a joint statement published in 2019. Building on ICMRA’s AMR commitment, a […]
Public Alert No:0043 – Products Contaminated With Ethylene Glycol And/Or Diethylene Glycol
, The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying Healthcare providers and the public of eight (8) substandard products, identified in the WHO Region of South-East Asia. These products were identified in Indonesia and publicly reported by the national regulatory authority (Badan POM) on 20 and 30 October 2022. These […]